I was impressed by not only the GTCB staff but by David Onions, President, Q-One Biotech Limited "Ensuring the Viral & Microbiological Safety of Biopharmaceuticals Produced from Transgenic Goat's Milk "
Is there anything he didn't cover that the FDA could raise?
The only other fly I see in the potential use of transgenic protiens [and I profess no knowledge in this department] is that at some time in the future they would be able to construct equivalent complex proteins artifically. But given why they are trying to produce them transgenically I see that that threat is as least 5 years out if not more. Why else is NIH interested (in Malaria vaccine)?
So how long will it take the euros to act on ATryn® ? 1Q05? Am I right that that would be the next big event for the company?
Market Data 
Markets 
AI
